5-Bromo-2-chlorobenzoic acid
-
Dapagliflozin intermediates
|
|
Apixaban
-
Apixaban
Cardiovasculars
|
|
Aripiprazole
-
Aripiprazole
Anti-Psychotic
|
|
Saxagliptin hydrate
-
Saxagliptin
anti-diabetics
|
|
Tenofovir disoproxil fumarate
-
Tenofovir
HIV
|
|
(1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium
-
Ticagrelor intermediates
|
|
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester
-
Saxagliptin intermediates
|
|
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile
-
Vildagliptin intermediates
|
|
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
-
Teneligliptin intermediates
|
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine
-
Sitagliptin intermediates
|
|
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one
-
Sitagliptin intermediates
|
|
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
-
Empagliflozin intermediates
|
|
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan
-
Empagliflozin intermediates
|
|
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
-
Dapagliflozin intermediates
|
|
(R)-3-(Boc-Amino)piperidine
-
Alogliptin intermediates
|
|
(R)-3-Aminopiperidine dihydrochloride
-
Alogliptin intermediates
|
|
(R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate
-
Suvorexant Intermediates
|
|
(S)-(+)-N-(2,3-Epoxypropyl)phthalimide
-
Rivaroxaban intermediates
|
|
(S)-3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine, N-acetyl-glutarate
-
Repaglinide intermediates
|
|
1-(2,3-Dichlorophenyl)piperazine hydrochloride
-
Aripiprazole intermediates
|
|
1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine
-
Teneligliptin intermediates
|
|
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4);5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride (1:4)
-
Daclatasvir Intermediates
|
|
1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)-
-
Daclatasvir Intermediates
|
|
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid
-
Ticagrelor intermediates
|
|
2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID
-
Suvorexant Intermediates
|
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
-
Canagliflozin intermediates
|
|
2-(4-Fluorophenyl)thiophene
-
Canagliflozin intermediates
|
|
2-(Chloromethyl)-4-methylquinazoline
-
Linagliptin intermediates
|
|
2,5-Dichlorobenzooxazole
-
Suvorexant Intermediates
|
|
2-[(5-Bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene
-
Canagliflozin intermediates
|
|
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyrimidinyl)Methyl]
-
Alogliptin intermediates
|
|
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone
-
Prasugrel intermediates
|
|
2-Cyano-5-fluorobenzyl bromide
-
Trelagliptin intermediate
|
|
2-Cyanobenzyl bromide
-
Alogliptin intermediates
|
|
2-oxo-2,4,5,6,7,7a-hexahydrothieno [3, 2-c] pyridine. Hydrochloride
-
Prasugrel intermediates
|
|
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
-
Sitagliptin intermediates
|
|
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone
-
Aripiprazole intermediates
|
|
3-amino-1-adamantanol
-
Vildagliptin intermediates
|
|
3-Ethoxy-4-ethoxycarbonyl phenylacetic acid
-
Repaglinide intermediates
|
|
4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate)
-
Suvorexant Intermediates
|
|
4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate)
-
Suvorexant Intermediates
|
|
4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate)
-
Suvorexant Intermediates
|
|
4-(4-Aminophenyl)morpholin-3-one
-
Rivaroxaban intermediates
|
|
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether
-
Dapagliflozin intermediates
|
|
4,5,6,7-Tetrahydrothieno[3,2,c] pyridine hydrochloride
-
Prasugrel intermediates
|
|
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine
-
Ticagrelor intermediates
|
|
5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone
-
Apixaban intermediates
|
|
5-Chlorobenzooxazole-2-thiol
-
Suvorexant Intermediates
|
|
5-Chlorothiophene-2-carboxylic acid
-
Rivaroxaban intermediates
|
|
5-Iodo-2-methylbenzoic acid
-
Canagliflozin intermediates
|
|
6-Chloro-3-methyluracil
-
Alogliptin intermediates
|
|
7-hydroxy-3,4-Dihydro-2(1H)-quinolinone
-
Aripiprazole intermediates
|
|
8-Bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione
-
Linagliptin intermediates
|
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
-
Linagliptin intermediates
|
|
Alogliptin Benzoate
-
Alogliptin INN
anti-diabetics
|
|
Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid
-
Sitagliptin intermediates
|
|
Boc-3-Hydroxy-1-adamantyl-D-glycine
-
Saxagliptin intermediates
|
|
Canagliflozin hemihydrate
-
Canagliflozin
anti-diabetics
SGLT2 inhibitors
|
|
Cyclopropyl 2-fluorobenzyl ketone
-
Prasugrel intermediates
|
|
Dabigatran etexilate
-
Dabigatran
Cardiovasculars
|
|
Daclatasvir (BMS-790052)
-
API for HCV
|
|
Dapagliflozin
-
Dapagliflozin
anti-diabetics
SGLT2 inhibitors
|
|
Diethyl (tosyloxy)methylphosphonate
-
Tenofovir intermediates
|
|
Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane
-
intermediate
|
|
ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate
-
Apixaban intermediates
|
|
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
-
Apixaban intermediates
|
|
lifenacin succinate
-
API
|
|
Linagliptin
-
Linagliptin
anti-diabetics
|
|
L-Prolinamide
-
Vildagliptin intermediates
|
|
Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
-
Sitagliptin intermediates
|
|
Picolinic acid
-
Fine Chemicals
|
|
Prasugrel
-
Prasugrel
Cardiovasculars
|
|
R-(+)-9-(2-Hydroxypropyl)adenine
-
Tenofovir intermediates
|
|
Repaglinide
-
Repaglinide
anti-diabetics
|
|
Riociguat
-
api
|
|
Rivaroxaban
-
Rivaroxaban
Cardiovasculars
|
|
Sitagliptin phosphate monohydrate
-
Sitagliptin INN
anti-diabetics
|
|
Sofosbuvir
-
API for HCV
|
|
Suvorexant (MK-4305)
-
API for nervous system
|
|
Teneligliptin HBr
-
Teneligliptin
anti-diabetics
|
|
Ticagrelor
-
Ticagrelor
Cardiovasculars
|
|
Trelagliptin succinate
-
Trelagliptin
anti-diabetics
|
|
Vildagliptin
-
vildagliptin INN
anti-diabetics
|
|
|